HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.

Abstract
Mucopolysaccharidosis type IVA (MPS IVA, Morquio A disease), a progressive lysosomal storage disease, causes skeletal chondrodysplasia through excessive storage of keratan sulfate (KS). KS is synthesized mainly in cartilage and released to the circulation. The excess storage of KS disrupts cartilage, consequently releasing more KS into circulation, which is a critical biomarker for MPS IVA. Thus, assessment of KS level provides a potential screening strategy and determines clinical course and efficacy of therapies. We have recently developed a tandem mass spectrometry liquid chromatography [LC/MS/MS] method to assay KS levels in blood. Forty-nine blood specimens from patients with MPS IVA [severe (n = 33), attenuated (n = 11) and undefined (n = 5)] were analyzed for comparison of blood KS concentration with that of healthy subjects and for correlation with clinical severity. Plasma samples were digested by keratanase II to obtain disaccharides of KS. Digested samples were assayed by LC/MS/MS. We found that blood KS levels (0.4-26 µg/ml) in MPS IVA patients were significantly higher than those in age-matched controls (0.67-4.6 µg/ml; P < 0.0001). It was found that blood KS level varied with age and clinical severity in the patients. Blood KS levels in MPS IVA peaked between 2 years and 5 years of age (mean 11.4 µg/ml). Blood KS levels in severe MPS IVA (mean 7.3 µg/ml) were higher than in the attenuated form (mean 2.1 µg/ml) (P = 0.012). We also found elevated blood KS levels in other types of MPS. These findings indicate that the new KS assay for blood is suitable for early diagnosis and longitudinal assessment of disease severity in MPS IVA.
AuthorsShunji Tomatsu, Adriana M Montaño, Toshihiro Oguma, Vu Chi Dung, Hirotaka Oikawa, Talita Giacomet de Carvalho, María L Gutiérrez, Seiji Yamaguchi, Yasuyuki Suzuki, Masaru Fukushi, Kazuhiro Kida, Mitsuru Kubota, Luis Barrera, Tadao Orii
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 33 Suppl 3 Pg. S35-42 (Dec 2010) ISSN: 1573-2665 [Electronic] United States
PMID20107903 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
Chemical References
  • Biomarkers
  • Keratan Sulfate
Topics
  • Adolescent
  • Adult
  • Biomarkers (blood)
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Chromatography, Liquid
  • Early Diagnosis
  • Humans
  • Infant
  • Keratan Sulfate (blood)
  • Middle Aged
  • Mucopolysaccharidosis IV (blood, diagnosis)
  • Predictive Value of Tests
  • Reproducibility of Results
  • Severity of Illness Index
  • Tandem Mass Spectrometry
  • Up-Regulation
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: